NCT00749801View on ClinicalTrials.gov

Efficacy and Safety of Geneferm Nattokinase

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

April 30, 2008

Conditions
Hyperlipidemia
Interventions
DRUG

Nattokinase

2 capsules in the morning and before bed-time daily

Trial Locations (1)

710

Chi Mei Medical Hospital, Tainan City

Sponsors
All Listed Sponsors
collaborator

GeneFerm Biotechnology Co., Ltd.

INDUSTRY

lead

Chi Mei Medical Hospital

OTHER